In pulmonary embolism, fibrinolytic therapy is responsible for -
Hemorrhage is the main complication of fibrinolytic therapy, so it is contraindicated in all situations where the risk of bleeding is increased - recent trauma, surgery, biopsies, stroke, peptic ulcer, aneurysms, bleeding disorders, diabetes, acute pancreatitis etc.)
Risk of haemorrhage
Prognosis good
Massive emboli
All of the above